KA
AFIB

Kerrisdale Advisers’s Acutus Medical Inc AFIB Stock Holding History

Kerrisdale Advisers’s Portfolio AFIB Stock Details AFIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,327,102
Closed -$11.7M – 61
2021
Q3 		$11.7M Buy
1,327,102
+432,815
+48% +$5.69M 1.27% 29
2021
Q2 		$15.2M Buy
894,287
+375,288
+72% +$5.49M 1.36% 29
2021
Q1 		$6.94M Buy
518,999
+464,125
+846% +$10.4M 0.53% 37
2020
Q4 		$1.58M Buy
+54,874
New +$1.49M 0.12% 60

Other funds holding AFIB

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Kerrisdale Advisers's AFIB Position: Q4 2021 in Review

Kerrisdale Advisers sold out of Acutus Medical Inc (AFIB) in Q4 2021, closing a stake of 1,327,102 shares — an estimated $11.7M sold.

Kerrisdale Advisers first reported a position in AFIB in Q4 2020 and held it in 4 quarters. The position peaked at $15.2M in Q2 2021. 71 funds tracked by Wall St. Rank hold AFIB as of Q4 2021.

  • Kerrisdale Advisers reported no remaining Acutus Medical Inc position as of Q4 2021 after selling out during the quarter.
  • Kerrisdale Advisers sold 1,327,102 Acutus Medical Inc shares in Q4 2021, an estimated $11.7M.
  • Kerrisdale Advisers first reported a position in Acutus Medical Inc in Q4 2020 and held it in 4 quarters.
  • Kerrisdale Advisers's Acutus Medical Inc position peaked at $15.2M in Q2 2021.
  • 71 funds tracked by Wall St. Rank held Acutus Medical Inc as of Q4 2021.

Based on Kerrisdale Advisers's 13F filing for Q4 2021, filed 14 Feb 2022.